Madison International Realty invests in AXA IM Alts European Life Sciences platform

Madison International Realty has invested in AXA IM Alts European Life Sciences platform. Following the investment, Madison owns a minority stake in, and has advisory participation of, Kadans Science Partner, which AXA IM Alts acquired in December 2020.

Madison believes the investment will allow Kadans to further progress its strategy for growth in Europe by undertaking new acquisition opportunities and continuing to build out its existing development opportunities.

The investment is Madison’s first in the European life sciences sector and follows a $200 million commitment made to IQHQ, a U.S. life sciences real estate owner, operator and developer, during 2020.

Kadans is a fully integrated developer, owner and operator of European science parks and lab offices with a defined focus and scale. Its portfolio currently comprises 167,000 square meters (tk square feet) of operating space across 22 assets in key research locations in the Netherlands, the United Kin